Successful commercialization of a biopharmaceutical product is dependent upon an effective, high-quality cell-line development process. While high-throughput analytical instruments often take center ...
“For many cell-based therapies, progress comes from connecting the right pieces at the right moment,” Klein said. “When ...
NEWARK, Del.--(BUSINESS WIRE)--QPS, a leading global contract research organization (CRO), is pleased to announce new laboratory services capabilities. The central laboratory, leukopak cell therapy ...